136 related articles for article (PubMed ID: 9137465)
1. Effect of ascorbate oxidase on radical intensity and cytotoxic activity of ascorbate.
Sakagami H; Satoh K
Anticancer Res; 1997; 17(2A):1163-6. PubMed ID: 9137465
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia.
Satoh K; Sakagami H; Nakamura K
Anticancer Res; 1996; 16(5A):2987-91. PubMed ID: 8917417
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radical intensity and cytotoxic activity of ascorbate by PSK and lignins.
Satoh K; Sakagami H; Nakamura K
Anticancer Res; 1996; 16(5A):2981-6. PubMed ID: 8917416
[TBL] [Abstract][Full Text] [Related]
5. Copper, but not iron, enhances apoptosis-inducing activity of antioxidants.
Satoh K; Kadofuku T; Sakagami H
Anticancer Res; 1997; 17(4A):2487-90. PubMed ID: 9252668
[TBL] [Abstract][Full Text] [Related]
6. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines.
Makino Y; Sakagami H; Takeda M
Anticancer Res; 1999; 19(4B):3125-32. PubMed ID: 10652601
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cytotoxic activity of ascorbate by Acer nikoense Maxim. Extracts.
Sakagami H; Anzai S; Goto S; Takeda M
Anticancer Res; 1997; 17(6D):4453-6. PubMed ID: 9494549
[TBL] [Abstract][Full Text] [Related]
9. Modulating factors of radical intensity and cytotoxic activity of ascorbate (review).
Sakagami H; Satoh K
Anticancer Res; 1997; 17(5A):3513-20. PubMed ID: 9413196
[TBL] [Abstract][Full Text] [Related]
10. Relationship between radical intensity and cytotoxic activity of dopamine-related compounds.
Kawase M; Motohashi N; Kurihara T; Inagaki M; Satoh K; Sakagami H
Anticancer Res; 1998; 18(2A):1069-74. PubMed ID: 9615767
[TBL] [Abstract][Full Text] [Related]
11. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
[TBL] [Abstract][Full Text] [Related]
12. The interaction between two antioxidants, sodium ascorbate and gallic acid: radical intensity and apoptosis induction.
Sakagami H; Satoh K
Anticancer Res; 1996; 16(3A):1231-4. PubMed ID: 8702242
[TBL] [Abstract][Full Text] [Related]
13. Radical intensity and cytotoxic activity of curcumin and gallic acid.
Nogaki A; Satoh K; Iwasaka K; Takano H; Takahama M; Ida Y; Sakagami H
Anticancer Res; 1998; 18(5A):3487-91. PubMed ID: 9858929
[TBL] [Abstract][Full Text] [Related]
14. Interaction between dental metals and antioxidants, assessed by cytotoxicity assay and ESR spectroscopy.
Kinoshita N; Yamamura T; Teranuma H; Katayama T; Tamanyu M; Negoro T; Satoh K; Sakagami H
Anticancer Res; 2002; 22(6C):4017-22. PubMed ID: 12553026
[TBL] [Abstract][Full Text] [Related]
15. Ascorbyl radical scavenging activity of polyphenols.
Satoh K; Sakagami H
Anticancer Res; 1996; 16(5A):2885-90. PubMed ID: 8917403
[TBL] [Abstract][Full Text] [Related]
16. Effect of metal ions on radical intensity and cytotoxic activity of ascorbate.
Satoh K; Sakagami H
Anticancer Res; 1997; 17(2A):1125-9. PubMed ID: 9137459
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
18. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds.
Kuribayashi N; Sakagami H; Sakagami T; Niimi E; Shiokawa D; Ikekita M; Takeda M; Tanuma S
Anticancer Res; 1994; 14(3A):969-76. PubMed ID: 8074500
[TBL] [Abstract][Full Text] [Related]
19. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
[TBL] [Abstract][Full Text] [Related]
20. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
Satoh K; Ida Y; Kochi M; Sakagami H
Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
